All Perspectives
9127 total results. Page 3 of 366.
On August 6, the US Food and Drug Administration (FDA) issued an update regarding the use of per- and polyfluoroalkyl substances (PFAS), specifically fluoropolymers such as polytetrafluoroethylene (PTFE), in medical devices. The FDA concluded that, based on current scientific evidence, there is no reason to restrict the continued use of fluoropolymers in medical devices.
Partner Ehsun Forghany was interviewed by Bloomberg Law about the new discretionary denial procedure implemented by US Patent and Trademark Office’s (USPTO) acting director, Coke Stewart, and how this policy shift has created uncertainty for both petitioners and patent owners in post-grant proceedings before the Patent Trial and Appeal Board (PTAB).
ArentFox Schiff delivered a complete victory for Tieks, a Los Angeles-based fashion brand known for its signature blue-soled flats, in a design patent-based investigation at the US International Trade Commission (ITC).
On July 31, the US Patent and Trademark Office (USPTO) issued a new memorandum announcing that it will begin enforcing 37 C.F.R. § 42.104(b)(4) that requires petitioners in inter partes review (IPR) proceeding to “specify where each element of the claim is found in the prior art patents or printed publications relied upon.”
On July 4, President Donald Trump signed into law P.L. 119-21, the “One Big Beautiful Bill Act” (OBBBA), which, among other notable changes to the US tax system, rolls back several renewable energy incentives enacted under the Inflation Reduction Act of 2022 (IRA) and creates new restrictions on renewable energy incentives for taxpayers with certain foreign entity connections, which are detailed below.
The court held that the statute of limitations began to run from the date when a former employee produced confidential company financial during discovery in an unrelated matter, and not from the earlier date when the former employee had copied and taken the files, because defendants had not failed to exercise reasonable diligence to uncover the alleged misappropriation.
On July 4, President Trump signed into law the “One Big Beautiful Bill Act (OBBBA),” more formally known as “H.R.1 – An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14.”
Headlines that Matter for Companies and Executives in Regulated Industries
On July 22, the US Senate passed the Maintaining American Superiority by Improving Export Control Transparency Act (the Bill), sending it to President Trump for his signature.
The Trump Administration is moving aggressively to prevent foreign adversaries’ ownership of US agricultural land.
On July 29, the Attorney General (AG) of the United States issued a memorandum entitled “Guidance For Recipients of Federal Funding Regarding Unlawful Discrimination” (hereinafter “Guidance”). This alert provides a review of the guidance and recommendations for consideration.
ArentFox Schiff advised Ramaco Resources, Inc., an operator and developer of high-quality, low-cost metallurgical coal and a developing producer of coal, rare earth, and critical minerals, in two public offerings totaling $265 million.
The Committee on Foreign Investment in the United States (CFIUS) is back in the spotlight.
This fall, Congress is poised to consider and develop legislation differing in type and scope — from funding measures to reconciliation proposals.
Latinvex has listed ArentFox Schiff among the top international law firms in Latin America, the 10th year receiving this recognition.
The District of Columbia’s Access to Justice (ATJ) Initiative is the primary local mechanism for public funding of civil legal services to low- and moderate-income DC residents.
On July 29, the US Environmental Protection Agency (EPA) announced a proposal to rescind its 2009 Endangerment Finding.
An association’s board often confronts difficult decisions. One that is particularly challenging is whether and how to remove a sitting director.
Food, Drug, Medical Device & Cosmetic Counsel Abha Kundi will deliver the opening presentation of the Healthcare Distribution Alliance’s (HDA) 2025 Traceability Seminar on August 5, 2025.
On July 31, the US Department of Health and Human Services’ (HHS) Health Resources and Services Administration (HRSA) announced the availability of a new pilot program altering how pharmaceutical manufacturers can honor the 340B price.
Customs & Import Compliance Practice Group Leader Angela Santos was quoted in a recent New York Times article discussing the swift actions taken by businesses to remove goods from “bonded warehouses” in response to the latest tariff threats from the Trump Administration.
After weeks of anticipation and a flurry of news from Washington, DC, the White House has issued a long-awaited executive order (EO) that resets the landscape for US reciprocal tariffs and related trade measures.
ArentFox Schiff is pleased to announce that Partner Rob Carrol has been named among the 2025 “Top Labor & Employment Attorneys in California” by Daily Journal, the state’s premier legal publication.
The climate debate has whipsawed in recent years. Businesses frequently have been caught in the middle, with stakeholders including government regulators, activist investors, consumers, non-governmental organizations, and community groups all pursuing different agendas.
Headlines that Matter for Companies and Executives in Regulated Industries